1. Home
  2. Stocks
  3. Indoco Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Indoco Remedies

    Small Cap
    ₹322.9
    -1.25 (-0.39%)
    • Advice
    • Hold
    27 July, 2024 07:08 BSE: 532612 NSE: INDOCO ISIN: INE873D01024

    Start SIP in Indoco Remedies

    Start SIP

    Indoco Remedies Performance

    Day Range

    • Low 320
    • High 327
    ₹ 322

    52 Week Range

    • Low 287
    • High 415
    ₹ 322
    • Open Price324
    • Previous Close324
    • Volume112649

    Indoco Remedies Share Price

    • Over 1 Month -1.06%
    • Over 3 Month -1.73%
    • Over 6 Month -11.33%
    • Over 1 Year + 1.86%

    Indoco Remedies Key Statistics

    P/E Ratio 38.8
    PEG Ratio -1
    Market Cap Cr
    Price to Book Ratio 2.7
    EPS 11.7
    Dividend 0.7
    Relative Strength Index 43.26
    Money Flow Index 29.33
    MACD Signal 0.88
    Average True Range 9.36
    Indoco Remedies Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 401445449473423427
    Operating Expenses Qtr Cr 350388384401360363
    Operating Profit Qtr Cr 525765726364
    Depreciation Qtr Cr 242423212018
    Interest Qtr Cr 121110889
    Tax Qtr Cr 597111013
    Net Profit Qtr Cr 153820332625
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,7991,669
    Operating Expenses Annual Cr 1,5331,382
    Operating Profit Annual in Cr 258285
    Depreciation Cr 8871
    Interest Annual Cr 3725
    Tax Annual Cr 3750
    Net Profit Annual Cr 117141
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 177176
    Cash from Investing Activity Annual Cr -302-205
    Cash from Financing Annual Activity Cr 12223
    Net Cash Flow Annual Cr -3-7
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,1271,027
    Fixed Assets Annual Cr 847774
    Total Non Current Assets Annual Cr 1,060853
    Total Current Assets Annual Cr 900807
    Total Assets Annual Cr 1,9611,660
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 122111
    ROE Annual % 1014
    ROCE Annual % 1318
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1517
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 431450459482427428
    Operating Expenses Qtr Cr 384401397410365363
    Operating Profit Qtr Cr 484963716165
    Depreciation Qtr Cr 282624212018
    Interest Qtr Cr 141210889
    Tax Qtr Cr 5117111013
    Net Profit Qtr Cr 32316352426
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,8271,671
    Operating Expenses Annual Cr 1,5731,383
    Operating Profit Annual in Cr 244286
    Depreciation Cr 9271
    Interest Annual Cr 3825
    Tax Annual Cr 3951
    Net Profit Annual Cr 98142
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 157179
    Cash from Investing Activity Annual Cr -434-208
    Cash from Financing Annual Activity Cr 28023
    Net Cash Flow Annual Cr 3-7
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,1101,028
    Fixed Assets Annual Cr 1,058792
    Total Non Current Assets Annual Cr 1,190850
    Total Current Assets Annual Cr 955808
    Total Assets Annual Cr 2,1451,658
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 120112
    ROE Annual % 914
    ROCE Annual % 1118
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1417
    Invest in Indoco Remedies

    Indoco Remedies Technicals

    EMA & SMA

    Current Price
    ₹322.9
    -1.25 (-0.39%)
    pointer
    • Bullish Moving Average
    • ___
    • 1
    • Bearish Moving Average
    • ___
    • 15
    • 20 Day
    • ₹328.98
    • 50 Day
    • ₹329.05
    • 100 Day
    • ₹333.13
    • 200 Day
    • ₹339.14
    • 20 Day
    • ₹333.48
    • 50 Day
    • ₹324.42
    • 100 Day
    • ₹329.99
    • 200 Day
    • ₹346.26

    Indoco Remedies Resistance and Support

    PIVOT
    ₹323.27
    Resistance
    First Resistance 326.48
    Second Resistance 330.07
    Third Resistance 333.28
    RSI 43.26
    MFI 29.33
    MACD Single Line 0.88
    MACD -1.23
    Support
    First Support 319.68
    Second Support 316.47
    Third Supoort 312.88

    Indoco Remedies Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 114,725 7,017,728 61.17
    Week 159,951 7,436,131 46.49
    1 Month 160,221 8,430,827 52.62
    6 Month 132,085 7,061,242 53.46

    Indoco Remedies Result Highlights

    Indoco Remedies Synopsis

    NSE-Medical-Diversified

    Indoco Remedies is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1666.69 Cr. and Equity Capital is Rs. 18.43 Cr. for the Year ended 31/03/2023. Indoco Remedies Ltd. is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913.
    Market Cap 2,977
    Sales 1,769
    Shares in Float 3.78
    No of funds 68
    Yield 0.46
    Book Value 2.64
    U/D Vol ratio 0.7
    LTDebt / Equity 19
    Alpha -0.1
    Beta 0.92

    Indoco Remedies Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 58.75%58.72%58.74%58.74%
    Mutual Funds 17.04%17.91%18.17%16.61%
    Insurance Companies 0.13%0.29%0.33%0.17%
    Foreign Portfolio Investors 1.48%1.92%1.69%1.59%
    Individual Investors 16.29%15.33%15.23%16.84%
    Others 6.31%5.83%5.84%6.05%

    Indoco Remedies Management

    Name Designation
    Mr. Suresh G Kare Chairman
    Ms. Aditi Panandikar Managing Director
    Mr. Sundeep V Bambolkar Joint Managing Director
    Dr. Anand Nadkarni Non Executive Director
    Mr. D M Gavaskar Independent Director
    Mr. Rajiv P Kakodkar Independent Director
    Dr.(Ms.) Vasudha V Kamat Independent Director
    Mr. Abhijit Y Gore Independent Director

    Indoco Remedies Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Indoco Remedies Corporate Action

    Date Purpose Remarks
    2024-07-23 Quarterly Results
    2024-05-16 Audited Results & Final Dividend
    2024-01-23 Quarterly Results
    2023-10-19 Quarterly Results
    2023-07-25 Quarterly Results

    Indoco Remedies MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 56,469
    Quant Small Cap Fund Growth 22,967
    HDFC Multi Cap Fund Regular Growth 15,564
    Franklin India Smaller Companies Fund Growth 14,023
    ICICI Prudential Smallcap Fund Growth 8,438

    Indoco Remedies FAQs

    What is Share Price of Indoco Remedies ?

    Indoco Remedies share price is ₹322 As on 27 July, 2024 | 06:54

    What is the Market Cap of Indoco Remedies ?

    The Market Cap of Indoco Remedies is ₹2976.6 Cr As on 27 July, 2024 | 06:54

    What is the P/E ratio of Indoco Remedies ?

    The P/E ratio of Indoco Remedies is 38.8 As on 27 July, 2024 | 06:54

    What is the PB ratio of Indoco Remedies ?

    The PB ratio of Indoco Remedies is 2.7 As on 27 July, 2024 | 06:54

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.